GuidelineWiener klinische Wochenschrift2013
Austrian consensus on the definition and treatment of portal hypertension and its complications (Billroth II).
Guideline in Wiener klinische Wochenschrift, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Impact of Underlying Portal Hypertension on Severity and Course of Acute-On-Chronic Liver Failure.Liver international : official journal of the International Association for the Study of the Liver · 2025Article
- Covered Transjugular Intrahepatic Portosystemic Shunt Improves Hypersplenism-Associated Cytopenia in Cirrhosis.Digestive diseases and sciences · 2022Article
- The impact of ABO blood type on the prevalence of portal vein thrombosis in patients with advanced chronic liver disease.Liver international : official journal of the International Association for the Study of the Liver · 2020Article
- von Willebrand Factor Antigen Predicts Outcomes in Patients after Liver Resection of Hepatocellular Carcinoma.Gut and liver · 2020Article
- The value of different CT-based methods for diagnosing low muscle mass and predicting mortality in patients with cirrhosis.Liver international : official journal of the International Association for the Study of the Liver · 2019Article
- Ascitic fluid polymorphic nuclear cell count impacts on outcome of cirrhotic patients with ascites.United European gastroenterology journal · 2019Article
- Dysbalanced sex hormone status is an independent predictor of decompensation and mortality in patients with liver cirrhosis.Hepatology research : the official journal of the Japan Society of Hepatology · 2019Article
- Erectile dysfunction in cirrhosis is impacted by liver dysfunction, portal hypertension, diabetes and arterial hypertension.Liver international : official journal of the International Association for the Study of the Liver · 2018Article
- Transjugular intrahepatic portosystemic shunts (TIPS) for the prevention of variceal re-bleeding - A two decades experience.PloS one · 2018Article
- Study of the association between hemorrhage and the position of hemorrhagic stigmata in patients with esophageal varices.Experimental and therapeutic medicine · 2017Article
- Low 25-OH-vitamin D levels reflect hepatic dysfunction and are associated with mortality in patients with liver cirrhosis.Wiener klinische Wochenschrift · 2017Article
- [Hepatocardiac disorders : Interactions between two organ systems].Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2016Review
- Article
- The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection.PloS one · 2015Article
- Therapeutic effects and complications of simplified pericardial devascularization for patients with portal hypertension.International journal of clinical and experimental medicine · 2015Article
- Utility of endoscopic ultrasound in patients with portal hypertension.World journal of gastroenterology · 2014Review
- HPS: Diagnosis, clinical features, and medical therapy.Clinical liver disease · 2014Article
- [Pulmonary complications in liver diseases].Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2014Review
- Article
- Association of Cirrhosis and Cardiomyopathy.Euroasian journal of hepato-gastroenterologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In November 2004, the Austrian Society of Gastroenterology and Hepatology (ÖGGH) held for the first time a consensus meeting on the definitions and treatment of portal hypertension and its complications in the Billroth-Haus in Vienna, Austria (Billroth I-Meeting). This meeting was preceded by a meeting of international experts on portal hypertension with some of the proponents of the Baveno consensus conferences (http://www.oeggh.at/videos.asp). The consensus itself is based on the Baveno III consensus with regard to portal hypertensive bleeding and the suggestions of the International Ascites Club regarding the treatment of ascites. Those statements were modified by new knowledge derived from the recent literature and also by the current practice of medicine as agreed upon by the participants of the consensus meeting. In October 2011, the ÖGGH organized the second consensus meeting on portal hypertension and its complications in Vienna (Billroth II-Meeting). The Billroth II-Guidelines on the definitions and treatment of portal hypertension and its complications take into account the developments of the last 7 years, including the Baveno-V update and several key publications.
Indexed as
Identifiers
23579878What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.